What to watch with Homocystein and menopause?

Homocysteine is a risk marker for cardiovascular disease, and during menopause the decline in estrogen increases cardiovascular risk. Elevated homocysteine may indicate deficiencies in vitamin B12, folate, or B6, or genetic variants like MTHFR C677T. However, evidence for routine homocysteine screening in menopause is mixed: some studies link it to cardiovascular events, others do not. Supplementing B vitamins lowers homocysteine but does not consistently reduce heart attack or stroke risk. Testing is reasonable if additional risk factors are present (e.g., family history, vegan diet, gastrointestinal issues). A normal level (<10–12 µmol/L) is reassuring but not a guarantee. Caveat: Do not self-prescribe high-dose B vitamins without medical guidance. During menopause, other markers (lipids, glucose, blood pressure) are often more actionable. Overall, homocysteine is one piece of the puzzle, not a standalone predictor.